Member Info for Dr_Horrible

Dr. Robert E. Steinert, Principal Scientist at DSM comments: “DSM is committed to helping people improve their gut health and use this as a gateway to overall wellbeing. The results of this study are incredibly encouraging and support earlier findings that polyphenol-rich extracts can lower TMAO concentrations through a targeted and beneficial modulation of the gut microbiota. We’re looking forward to working with our customers to develop new dietary supplement solutions targeting the gut-heart axis. Looking ahead, this study paves the way for future research into the gut-brain axis, especially age-related cognitive decline. This is an exciting time for gut-health research.”

https://www.dsm.com/human-nutrition/en/talking-nutrition/press-releases/2023-01-20-new-study-reveals-dsms-fruitflow-activates-gut-heart.html

It is strange that DSM have papers around why FF is beneficial to menopause, but then don't use it themselves with Phenology.

https://www.dsm.com/human-nutrition/en_ES/talking-nutrition/5-ways-fruitflow.html

The gut health opportunity with DSM is massive. It just remains to be seen whether they actually do anything with it. If they are serious about it, we will see it appear in their own products like Culturelle, Hologram, Up4 etc. If not, it will just be at a few trade shows and slowly get customers like FF did.

If you are stupid, we'll all stupid. Most of us here are in the same boat. However, the next 5 years appear to be massively different than the last 5 years. We should move into profit in the next financial year.

A new Chinese article referencing the SIPA study.
https://www.prnasia.com/story/376755-1.shtml

and maybe
https://up4products.com
or
https://estroven.com

a couple more of their brands.

I am hoping that DSM lead the way and include FF in their Culterelle Brand. Given the gut health study results, it seems the obvious place to start.
https://www.culturelle.com

So long as it's Fruitflow, I don't mind what they call it :)

Very similar with some minor differences, but mainly different people funding it. Perhaps the original one was being delayed and then BH jumped in to fund it themselves.

Primary sponsor:
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Source(s) of funding:
Self-financing

So it is not a By-Health study.

This is very good. It shows that the aim is to use FF for primary prevention.

Gix,

There is more data in this link:
https://www.chictr.org.cn/showproj.aspx?proj=130349

The purpose of this study is to evaluate the effect and safety of Xinluosu Tablets on platelet function in healthy population, so as to prevent abnormal platelet activation and aggregationand reduce the risk of cardiovascular disease.

Size: 50 people
Tablet size: 300mg
Institution: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Age 35 - 65 years
Sex: Both

Outcomes:
platelet aggregation function - Primary indicator
platelet activating function - Primary indicator
platelet release function - Primary indicator
platelet adhesion function - Primary indicator
stature - Secondary indicator
weight - Secondary indicator
waist circumference - Secondary indicator
hip circumference - Secondary indicator
blood pressure - Secondary indicator
heart rate - Secondary indicator
Score of TCM constitution - Secondary indicator
blood routine test - Secondary indicator
hepatic function test - Secondary indicator
renal function test - Secondary indicator
blood lipid test - Secondary indicator
hemagglutination test - Secondary indicator

An overview of Healthy China 2030.
https://youtu.be/ET29MY5yN2g

Some more vids

Or CircuAce adverts
https://youtu.be/oO3DCzdnyJk
https://youtu.be/0y_OfykBjGk
https://youtu.be/PZyIOlnB5wE
https://youtu.be/u2cOsKZvZ_g

Probiotica Beta Pro
https://youtu.be/WWouBn0WJt4

CardioFortis
https://youtu.be/tvy1kHBT4uA

I like to see FF adverts.
https://youtu.be/gTUguw_BNJI

It’s not new, but does show companies putting an effort in.

The early studies by Duttaroy always seem to be followed up, like the TMAO one. Somebody must be following up on blood pressure and Coivd 19. I would guess BH for Covid-19 as it represents a huge opportunity for them.

The update wasn't really an update, it didn't update us on anything, like...

How is the work to progress FF as a drug, has that got started?
Is the transfer from DSM to PXS complete? If not, why not?
Why did the outstanding By-Health Studies not complete and what is the new forecast completion date?
What is happening with getting FF+ Omega3 into other shops etc?
What happed to the Fruitflow app for mobile devices?
What is happening with the Liverpool research work?
What is happening with blood pressure work? We did a small trial, said yeh it works and that's it?
etc

RNS damp squib

That said, the future looks very good. They are still forecasting that the "prospective sales pipeline for Fruitflow continues to stand at a substantial multiple of existing annual sales." If only we knew what existing Fruitflow sales were or what was meant by 'substantial multiples', and a broad timeline would be nice.

Asia Health King CTC

https://www.ahk.com.tw/pages/ctc?fbclid=IwAR3t79qSJfXEY8EIbCfmjQhaNFpSCIj7ZBshTUXQ6ByvBkJusvy6TiaeoEc

Those strict rules will favour PXS and BH because only they will have access to the health claim for 5 years. This comes at a time when the trend for the next 5 years is to address healthy aging. It’s the focus of all the big VDS companies.